ArticleScientific data2025
ScRNA profiling of peripheral blood in kidney transplant recipients across rejection responses and treatments.
Article in Scientific data, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Studies have reported diverse functions of immune cells in response against the transplanted kidney, highlighting their significant roles in immunosuppressive response. Peripheral blood analyses showed differences in immune cell composition between kidney transplant recipients and healthy donors, however, the differences in peripheral blood immune landscape between patients with different rejection types and treatment phases remain unclear. Here, we present a single-cell RNA sequencing (scRNA-seq) dataset of peripheral blood cells derived from five participants after kidney transplantation. The dataset comprises 98,595 quality-control passed cells along with clinical metadata, enabling a comparative analysis of immune cell populations before and after immunosuppression treatment as well as between different rejection types. We preliminarily identified major cell types including immune and non-immune cells, and further annotated the immune cell subsets. This transcriptomic data will serve as a resource to explore new cellular biomarkers and microenvironmental changes in peripheral blood of kidney recipients with different reaction types, and to deepen our insights into the role of immunosuppression treatment on graft rejection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.